Earlybird Health
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage
Geographical Focus
United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Ireland, Austria, Netherlands, Hungary, Portugal, Sweden, Belgium, Greece, Norway, Finland, Poland, Czech Republic, Romania
Industries Focus
- Healthcare
- HealthTech
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Medtech
- Biotechnology
- Health Services
- Medical Research
- Clinical Trials
- Medical Equipment
- Health Insurance
- E-health
- Biopharma
- Health IT
- Telemedicine
- Health Policy
- R&D Tools
- Health Data Analytics
Investment Size:
500,000 to 10,000,000 USD
Investor Details Founded: 2024
Earlybird Health is a venture capital firm dedicated to investing in European healthcare innovations that aim to enhance patient outcomes. The firm focuses on a wide range of sectors within the healthcare industry, including digital health, diagnostics, medical devices, R&D tools, and biopharmaceuticals. By supporting these areas, Earlybird Health seeks to drive advancements that positively impact the healthcare landscape across Europe.
The firm's investment strategy encompasses various stages of company development, from seed and early-stage investments to growth and late-stage funding. This approach allows Earlybird Health to support companies at different points in their growth trajectory, providing the necessary resources and expertise to scale effectively. The firm's geographical focus spans multiple European countries, reflecting its commitment to fostering innovation throughout the continent.
Earlybird Health's track record includes the successful closing of its second fund in February 2024, raising €173 million. This fund is more than twice the size of its predecessor, indicating increased investor interest in healthcare ventures. The firm leverages proprietary tools like EagleEye, an AI and data platform, to enhance its investment processes and gain market intelligence. Additionally, Earlybird Health uniquely includes public health insurers as cornerstone investors, incorporating a payer's perspective into its investment approach.
Requirements
- Innovative healthcare solutions
- Strong founding teams
- Scalable business models
- Positive patient impact
- European market focus
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- ImCheck Therapeutics
- Medbelle
- Ada Health
- Clue
- Caresyntax
- Lilium
- BioNTech
- CureVac
- Mimi Hearing Technologies
- Kry
- Doctolib
- Babylon Health
- Zava
- Livi
- Klinikverbund Südwest
- Medigo
- MyTomorrows
- MediDate
Mentioned In
-
$49.95
-
$39.95
-
$24.95
-
$19.95
-
$19.95
-
$245.00
Claim this Investor
Are you an official representative of Earlybird Health?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim